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Objectives. We sought 1) to compare three pacing modalities—
DDDR with mode switching (DM), DDDR with conventional
upper rate behavior (DR) and VVIR (VR)—in patients with a
history of atrial tachyarrhythmias, and 2) to assess the efficacy of
six mode-switching algorithms.
Background. A history of atrial tachyarrhythmias has been a
relative contraindication to dual-chamber pacing. Several mode-
switching algorithms have recently been developed to prevent
rapid tracking of atrial tachyarrhythmias.
Methods. Forty-eight patients (mean age 64 years, 58% male)
with a history of atrial tachyarrhythmias and heart block had a
DM pacemaker implanted. Pacemakers were programmed to DM,
DR and VR modes for 4 weeks each in a randomized crossover
design. All subjects used a patient-activated electrocardiographic
(ECG) recorder throughout the study and additionally underwent
ambulatory ECG monitoring and a treadmill exercise test in each
mode. They completed three symptom questionnaires at the end of
each pacing period. At the end of the study, patients chose their
preferred pacing period.
Results. DM was significantly better than VR mode objectively
(exercise time DM 8.1 min, VR 7.0 min, p < 0.01) and subjectively
(perceived well-being DM 69, VR 51, p < 0.001; functional class
DM 2.2, VR 2.5, p < 0.05; subjective symptom score DM 21.2, VR
26.8, p 5 0.01). Patient-perceived well-being was significantly
better with DM than with DR mode (DM 69, DR 60, p 5 0.02). DM
mode was the preferred pacing period (DM 51%, DR 14%, VR
14%). Early termination of pacing because of adverse symptoms
was requested by 33% of patients during VR, 19% during DR but
only 3% during DM mode. A higher proportion of patients with a
fast mode-switching device preferred DM mode (fast 55%, slow
49%), whereas no patients with a fast mode-switching device chose
VR as the preferred mode (fast 0%, slow 19%). In the subgroup of
patients who had had atrioventricular node ablation, DM was also
preferred to VR mode (DM 53%, VR 27%). Overall, there were
only two cases of inappropriate mode switching and one case of
inappropriate tracking of an atrial tachyarrhythmia.
Conclusions. DM is the pacing mode of choice of patients with
paroxysmal atrial tachyarrhythmias. With optimal programming,
inappropriate mode switching and tracking of atrial tachyarrth-
mias was very uncommon.
(J Am Coll Cardiol 1997;30:496–504)
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Dual-chamber pacemakers will track atrial rates to the upper
rate limit in DDD mode. If the atrial rate exceeds the upper
rate limit, Wenckebach-like behavior will occur. Rapid track-
ing of atrial tachyarrhythmias in DDD mode can result in
adverse symptoms. A history of atrial tachyarrhythmias was
thus a relative contraindication to implantation of dual-
chamber pacemakers in the past. The disadvantage of single-
chamber ventricular pacing in these patients is the lack of
atrioventricular (AV) synchrony during periods of sinus
rhythm. This can result in symptoms of pacemaker syndrome
(1) and theoretically may exacerbate the frequency of the atrial
tachyarrhythmias (2).
A significant proportion of patients suitable for dual-
chamber pacemaker implantation have a history of atrial
tachyarrhythmias. They include patients with sinus node dis-
ease (tachybrady syndrome) and paroxysmal atrial fibrillation
with pathologic or iatrogenic (post AV node ablation) heart
block. Furthermore, long-term follow-up studies (3) have
shown that persistent atrial fibrillation occurs in 10% of
subjects with a dual-chamber pacemaker.
Several manufacturers have recently developed different
mode-switching algorithms in an attempt to extend the indica-
tions for dual-chamber pacing to patients with a history of
atrial tachyarrhythmias (4–7). In the presence of an atrial
tachyarrhythmia, a mode-switching pacemaker changes from
DDDR to a nontracking but atrial sensing mode (DDIR,
VDIR), pacing the ventricle at the sensor indicator rate; on
termination of the atrial tachyarrhythmia it resumes normal
DDDR function. These algorithms should thus protect the
patient from rapid ventricular rates during atrial tachyarrhyth-
mias while maintaining AV synchrony during sinus rhythm.
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DDDR with mode-switching capability (DM) pacemakers
are significantly more expensive than VVIR (VR) pacemakers.
Implantation of these pacemakers is also technically more
demanding. To date, there have been no randomized studies
comparing these two pacing modalities in patients with a
history of atrial tachyarrhythmias; thus, it is not known whether
DM pacing confers any additional clinical benefit over that of
simple VR pacing.
Study aims. In this study we sought 1) to compare DM
pacing with DDDR with standard upper rate behavior (DR)
and VR pacing in patients with a history of atrial tachyarrhyth-
mias; 2) to document the incidence and the factors contribut-
ing to inappropriate mode switching and inappropriate track-
ing of atrial tachyarrhythmias; and 3) to determine whether
there are differences in patients’ preferences for the different
mode-switching algorithms.
Methods
Patients. We recruited 48 consecutive patients who had a
history of atrial tachyarrhythmias before they underwent dual-
chamber pacemaker implantation. They had a mean age 6 SD
of 64 6 13 years; 28 patients (58%) were male. The predom-
inant arrhythmia was atrial fibrillation in 73% and atrial flutter
in the remaining 27%. The indications for pacing were heart
block in 8 patients (17%), AV node ablation in 17 (35%) and
sinus node disease with or without heart block in 23 (48%).
Other coexisting medical conditions included ischemic heart
disease in 33%, hypertension in 23% and history of treated
thyroid disease in 15%. All class I and III antiarrhythmic drugs
were discontinued before study induction. AV node blocking
agents such as beta-blockers, digoxin or calcium channel
antagonists were allowed in patients with intact AV conduction
to control the ventricular rate during episodes of recurrent
atrial tachyarrhythmias.
Study design. This was a randomized double-blind cross-
over study. Pacemakers were implanted and, for the 1st 30 days
after implantation, were programmed to DDIR mode. This
mode was not a study mode and acted as a “washout” period
during the postoperative recovery phase. The pacemakers were
then programmed in random order (by random number tables)
to each of the three pacing modes for a period of 4 weeks
each—DM, DR and VR. All patients were given transtele-
phonic self-activated electrocardiographic (ECG) devices for
the duration of the study and were instructed to send ECG
traces whenever they had symptoms. In addition, patients kept
a diary of all symptoms. Patients underwent continuous 24-h
ambulatory ECG Holter monitoring at the beginning of each
pacing mode. At the end of each 4-week study period, a
chronotropic assessment exercise protocol (8) (CAEP) test was
performed, and patients completed three self-administered
symptom questionnaires. The treadmill exercise tests were
supervised by a technician who did not know the patients’ study
modes.
Pacemaker Holter monitors were interrogated at 24 h and
at the end of each pacing period. Significant atrial tachyarrhyth-
mia was arbitrarily defined as a mean of .2,000 beats/day of
atrial arrhythmia on a pacemaker Holter monitor or atrial
tachyarrhythmia persisting for .30 s on 24-h ambulatory ECG
monitoring or throughout a transtelephonic ECG recording.
Patients with intolerable symptoms were allowed early cross-
over to the next study mode. At the end of the study, patients
were asked to choose their preferred pacing period.
Subjective assessment. Three self-administered question-
naires were used. The first utilized visual analog scales to assess
patient-perceived general well-being and exercise capacity (9).
Subjects were required to place a mark on a line 15 cm in
length from 0% (signifying extremely unwell or inability to
exercise) to 100% (extremely well or unlimited exercise capac-
ity). The result was expressed as a percent of the distance from
the discrete minimum point to the position of the mark divided
by the length of the line.
The second questionnaire assessed patients’ perception of
their functional capacity with use of the well validated Specific
Activity Scale functional status questionnaire (10). This grades
patients from class I (unlimited physical capacity) to IV
(grossly incapacitated). Finally, the Specific Symptom Preva-
lence questionnaire was used to assess the incidence and
frequency of symptoms of mild heart failure or pacemaker-
induced hemodynamic dysfunction. The symptom prevalence
score was calculated by using 11 cardiovascular-related symp-
toms (11). The minimal score was 0 (no symptoms) and the
maximal score was 84 (a score $25 has previously been shown
to be suggestive of pacemaker syndrome or moderate heart
failure).
Pacemakers. Six pacemakers were studied (Table 1). The
Diamond DR (Vitatron) uniquely utilizes a mode-switching
algorithm based on the rate of change of atrial rate; the
algorithms of the other five are based on a programmable
number of atrial events above a certain absolute rate limit.
Pacemaker mode-switching algorithms were defined as fast
(mode switching occurs with #5 beats of detected atrial
tachyarrhythmia [Diamond, Meta 1254]) or slow (mode switch-
ing occurs after a minimum of 10 beats of detected atrial
tachyarrhythmia [Vigor DR, Chorus RM] or when the mode
switching algorithm is dependent on a calculated mean atrial
rate [Thera DR, Trilogy DR1]).
Pacemaker programming. All pacemakers were pro-
grammed in conjunction with a research representative from
Abbreviations and Acronyms
AV 5 atrioventricular
DDD 5 dual-chamber universal mode
DDDR 5 dual-chamber universal rate-responsive mode
DM 5 DDDR with mode switching
DR 5 DDDR pacing with conventional upper rate behavior
ECG 5 electrocardiogram, electrocardiographic
VR 5 VVIR pacing
VVIR 5 single-chamber ventricular-inhibited rate-responsive
pacing
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each manufacturer present in an advisory capacity with the sole
aim of achieving optimal rate-response and mode-switching
programming for each study patient. The lower rate limit was
programmed to 60 beats/min, and the maximal tracking rate
was based on each patient’s age and concurrent clinical
diagnoses. The sensitivity of the atrial channel was set at 0.25
to 0.5 mV; the atrial blanking period was programmed to the
shortest value in the absence of far field sensing, to maximize
sensing of atrial tachyarrhythmias. The sensor rate response
was optimized at the end of the washout period by using a
standardized daily activity protocol (12). Thereafter, all rate-
response variables were kept constant for each patient
throughout the study. The mode-switching option in the Dia-
mond DR can be programmed to either “auto” or “fixed.” In
this study it was programmed to auto. Because the mode-
switching function in this device cannot be turned off, we
programmed a long atrial blanking period of 200 ms and
switched the mode to fixed, thus mimicking conventional DR
mode.
Statistical analysis. Results are reported as mean value 6
SD. A paired Student t test was used for within-patient
comparison of parametric data. Discrete variables were com-
pared by using the Wilcoxon signed rank test. Whenever more
than two comparisons were undertaken of a given variable, the
Bonferroni correction was utilized. Multiple stepwise logistic
regression was used to determine predictors of early termina-
tion of VR mode. All analyses were performed by using SPSS
for Windows statistical package. A p value , 0.05 was consid-
ered significant.
Results
Chronic atrial arrhythmia. Chronic atrial tachyarrhythmia
developed in five patients (10%). All five were found to have
atrial tachyarrhythmia at the end of the washout period, and
the arrhythmia persisted continuously throughout the 12-week
study period. Consequently, these five patients were excluded
from the overall analysis. In these patients DM was compared
with VR mode. Three of the five patients preferred DM mode,
and two had no preference, suggesting that the pacemakers
had switched mode appropriately throughout; all five patients
denied awareness of palpitation.
Subjective Assessment
Intolerable symptoms. Thirty-three percent of patients ter-
minated VR mode pacing early because of severe symptoms
consistent with pacemaker syndrome. Nineteen percent of
patients requested early crossover during DR mode because of
troublesome palpitation or fatigue, or both. Early termination
of this mode increased to 29% in the subgroup of patients with
significant atrial tachyarrhythmias. Only one patient (3%)
terminated DM mode early, and the cause was found to be
inappropriate tracking of atrial tachyarrhythmias. Clinical vari-
ables analyzed in an attempt to find predictors of early
termination of the VR mode included age, gender, pacemaker
model, etiology, anterograde AV conduction, intact ventricu-
loatrial conduction and amount of atrial arrhythmia; none of
these predicted early termination. All patients who terminated
the DR mode early had significant atrial tachyarrhythmias
during the study period.
Visual analog scales (Fig. 1). Patient-perceived well-being
was significantly higher with DM than with VR mode (DM
69 6 21%, VR 51 6 27%, p , 0.001) or DR mode (DM 69 6
21%, DR 60 6 25%, p 5 0.02). Patient-perceived exercise
capacity was also higher with DM (53 6 27%) than with VR
mode (43 6 26%) but this difference was not statistically
significant (p 5 0.08).
Table 1. Pacemakers and Mode-Switching Algorithms
Pacemakers
Mode
Switches
to Mode Switch Algorithm
Diamond DR (Vitatron) (8 patients) DDIR Based on the rate of change of atrial rhythm; atrial rates within a “physiologic band” are tracked;
mode switching occurs if rate of change exceeds upper limit of the band (fast mode-switching
device).
Meta 1254 (Telectronics) (3 patients) VR Mode switching occurs if the atrial rate exceeds a programmable atrial tachycardia detection rate
(independent of upper rate limit); the number of atrial events required for mode switching was
programmed to 5 (fast mode-switching device).
Vigor DR (CPI) (13 patients) VVIR Mode switching occurs if atrial rate exceeds upper rate limit; minimum of 8 atrial beats required for
arrhythmia detection; mode switching occurs after a further number (10 to 2,000) of atrial events
(slow mode-switching device).
Chorus RM (ELA) (4 patients) VR Mode switching occurs after a programmable number of atrial events (10 to 2,000) above upper rate
limit (slow mode-switching device).
Thera DR (Medtronic) (10 patients) DDIR Mode switching occurs if the mean atrial rate exceeds atrial tachycardia detection rate (independent
of upper rate limit). In the presence of atrial tachyarrhythmia, the mean atrial rate is
decremented by a fixed value per atrial event; mode switching occurs when mean atrial rate is
greater than the atrial tachycardia detection rate (slow mode-switching device).Trilogy DR1 (Pacesetter) (10 patients) DDIR }
DDIR 5 atrioventricular sequential dual-chamber inhibited rate-responsive nontracking but atrial sensing mode; VR 5 VVIR (single-chamber ventricular-
inhibited rate-responsive) pacing mode.
498 KAMALVAND ET AL. JACC Vol. 30, No. 2
MODE SWITCHING IN ATRIAL TACHYARRHYTHMIAS August 1997:496–504
Functional class and subjective symptom scores (Table 2).
Functional class and subjective symptom questionnaire scores
were significantly lower with DM than with VR mode (i.e.,
patients were less symptomatic), but there was no significant
difference between DM and DR modes.
Preferred pacing period (Fig. 2). Overall, 51% of patients
preferred DM mode. Only 14% chose VR or DR as their
preferred pacing period. Patient preference differed according
to whether or not significant atrial tachyarrhythmias occurred
during the study period. Of the 15 patients (35%) with little or
no atrial tachyarrhythmia, 47% preferred DM mode, 33% had
no preference and no one chose VR mode. Of the 28 patients
(65%) with significant atrial tachyarrhythmias, a higher pro-
portion (54%) preferred DM mode, only 4% had no prefer-
ence and 28% preferred VR mode or had no preference
between DM and VR modes.
Preferred pacing period according to mode-switching algo-
rithm (Fig. 3). Pacing period preference of the patients was
analyzed according to whether the pacemaker was defined as a
fast or slow mode-switching device. A higher proportion of
patients with a fast mode-switching device preferred DM mode
(fast 55%, slow 49%). No patient with a fast mode-switching
device chose VR mode, whereas 19% with a slow mode-
switching device preferred this mode. The six patients with a
slow mode-switching device who preferred VR mode had
frequent daily episodes of atrial tachyarrhythmias. All were
aware of recurrent short-lived palpitation lasting only a few
seconds during DM mode pacing. The 24-h ambulatory ECG
confirmed initial tracking of atrial tachyarrhythmias for several
beats before mode switching occurred.
Objective Assessment
Graded exercise treadmill tests (Table 2). The mean exer-
cise time and peak heart rate were significantly greater with
DM than with VR mode, but there was no difference between
DM and DR modes.
Inappropriate tracking or mode switching. Inappropriate
mode switching occurred in two patients. Only one case of
inappropriate tracking of atrial tachyarrhythmia documented
on 24-h ambulatory ECG monitoring, occurred with DM mode
pacing.
Patients With AV Node Ablation
A subgroup of 17 patients (mean age 56 6 13 years, 10
[59%] male) underwent AV node ablation for drug-refractory
atrial tachyarrhythmias before entry into the study. Of the 17
implanted pacemakers, 15 were slow mode-switching devices.
Chronic atrial tachyarrhythmia developed in two patients, who
Figure 1. Patient-perceived exercise capacity (ET) and gen-
eral well-being (GW). VAS 5 visual analog score (0% 5
unable to exercise/extremely unwell; 100% 5 unlimited
exercise capacity/extremely well).
Table 2. Comparison of Exercise Time, Peak Heart Rate, Functional Class and Subjective Symptom
Score Among the Three Pacing Modes
DR DM VR p Value*
EX time (min) 7.6 6 3.6 8.1 6 3.6 7.0 6 3.8 DM:DR 0.1
DM:VR , 0.01
Peak EX HR (beats/min) 128 6 20 128 6 18 116 6 21 DM:DR 0.8
DM:VR , 0.001
Functional class QS 2.1 6 0.8 2.2 6 0.9 2.5 6 1.0 DM:DR 0.5
DM:VR , 0.05
Subjective symptoms QS† 22.3 6 12.2 21.2 6 12.4 26.8 6 15.3 DM:DR 0.4
DM:VR 0.01
*A p value , 0.05 is statistically significant. †A score .25 is suggestive of pacemaker syndrome or moderate heart
failure. Data are expressed as mean value 6 SD. DM 5 DDDR with mode switching; DR 5 DDDR with conventional
upper rate behavior; EX 5 exercise; HR 5 heart rate; QS 5 questionnaire score; VR 5 VVIR.
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were excluded from further analysis. Forty-seven percent of
the remaining 15 patients requested early crossover because of
adverse symptoms during DR mode versus 20% during VR
mode and 7% during DM mode. Overall, 53% of the patients
chose DM mode as their preferred pacing period and 27%
preferred VR mode; no one chose DR mode. Patients could
exercise longer with DM mode than with VR mode (DM 8.9 6
3.2 min, VR 7.5 6 3.4 min, p , 0.05), and were less
symptomatic with this mode as assessed by subjective symptom
questionnaire (DM 23 6 12, VR 27 6 15, p , 0.05). There
were no significant differences between the two modes in
patient-perceived exercise capacity, well-being or functional
class.
Discussion
Alternatives to mode switching. There are several possible
methods of dealing with paroxysmal atrial tachyarrhythmias in
DR mode. 1) The atrial sensitivity could be set to sense and
track the atrial electrogram in sinus rhythm but not the lower
amplitude signal of atrial fibrillation. However, such a setting is
often not possible to achieve as there is no clear separation of
amplitude during sinus rhythm and atrial tachyarrhythmia. 2)
The pacemaker could be programmed to DDIR mode (13).
Loss of AV synchrony will occur if the sinus rate exceeds the
lower rate limit or the sensor-indicated rate (14). 3) In some
devices, the maximal sensor rate can be programmed to be
higher than the maximal tracking rate. This method prevents
rapid tracking of atrial tachyarrhythmia while allowing high
sensor-driven upper rates in response to exercise. The disad-
vantage is the occurrence of pacemaker Wenckebach phenom-
ena at relatively low atrial rates during sinus rhythm. 4) Finally,
conditional ventricular tracking limit (CVTL, Intermedics) can
limit the ventricular pacing rate in the presence of an atrial
tachyarrhythmia if there is no or minimal sensor activity
(15–17). However, with physical activity the conditional limit is
disabled, and the pacemaker tracks the atrial arrhythmia to the
programmed upper rate with rapid irregular ventricular pac-
ing. Thus, disadvantages are that a) the ventricular rate is
highly irregular during atrial tachyarrhythmias, and b) Wencke-
bach phenomena can occur during sinus rhythm, also causing
wide variation in ventricular pacing rate (18).
Figure 2. Preferred pacing period. Upper panels, Preferred modes in
patients with no atrial tachyarrhythmias (AT) (left) or significant AT
(right); Bottom panel, Overall preferred modes. DM/DR 5 no
preference between DM or DR; DM/VR 5 no preference between
DM or VR; NONE 5 no preference among the three modes.
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Mode-switching algorithms. In first-generation devices, in-
appropriate mode switching occurred in response to isolated
atrial and ventricular extrasystoles with retrograde ventricu-
loatrial conduction, or in response to sinus tachycardia (18,19).
The specificity of these devices for the detection of atrial
tachyarrhythmias was thus low. To increase this specificity,
several different mode-switching algorithms have since been
developed.
During this study, we observed that slow mode-switching
devices can take several seconds to recognize an atrial tachy-
arrhythmia, resulting in a delay in mode switching. During this
initial period, the atrial tachyarrhythmia is tracked at rapid and
irregular rates, and in some patients this tracking was associ-
ated with troublesome symptoms (Fig. 4). Thus, in an attempt
to increase the specificity of these devices, the sensitivity for
the detection and recognition of atrial tachyarrhythmias has
been lowered. This limitation should not pose a major problem
in patients with infrequent sustained atrial tachyarrhythmias.
However, in those with frequent brief atrial tachyarrhythmias,
it can result in adverse symptoms. This problem was not
encountered with the fast mode-switching devices such as the
Diamond DR and Meta 1254. With the Diamond device in
particular, even though mode switching occurred immediately
on detection of atrial tachyarrhythmia, there were no docu-
mented instances of inappropriate mode switching. This find-
ing may explain why none of the patients with a fast mode-
switching device preferred VR mode pacing, whereas 19%
with a slower device preferred this mode. Ideally, mode-
switching algorithms should be fully programmable so that
they can be tailored to the individual patient. However, until
such algorithms are available, it may be necessary to use
different devices for different patients depending on the char-
acteristics and frequency of their atrial arrhythmias.
AV node ablation. Ablation of the AV node is becoming an
increasingly popular treatment of medically refractory atrial
fibrillation. It reduces the number of hospital admissions and
antiarrhythmic drugs and improves quality of life (20). In our
study, DM mode pacing was preferred by the majority (53%)
of patients who had undergone AV node ablation. Patients
could exercise longer and were less symptomatic with this
mode than with VR mode. DR mode pacing was poorly
tolerated and was terminated early by 47% of patients. This
response was due to a high incidence of atrial tachyarrhyth-
mias. Twenty percent of patients terminated VR mode early
due to the development of symptoms of pacemaker syndrome.
Thus, DM mode pacing is the pacing preference of patients
who have undergone AV node ablation for drug-refractory
paroxysmal atrial fibrillation.
Inappropriate mode switching and tracking of atrial tachy-
arrhythmias. Inappropriate mode switching or arrhythmia
tracking was very uncommon in our study. The two patients
(one with Thera DR, one with Trilogy DR1) who had
inappropriate mode switching were both in their 40s and had
previously undergone AV node ablation. Their sinus rates
exceeded the atrial tachycardia detection rate of the pacemak-
ers (set at 170 beats/min) during treadmill exercise tests,
resulting in inappropriate mode switching. One patient (with a
Vigor DR) had inappropriate tracking of atrial tachyarrhyth-
mias on 24-h ambulatory ECG (frequent episodes of atrial
flutter with periods of mode switching as well as inappropriate
tracking). The pacemaker only intermittently recognized the
atrial arrhythmia, possibly because flutter waves fell within the
pacemaker atrial blanking period intermittently and conse-
quently were not sensed by the device.
The low incidence of inappropriate mode switching and
tracking of atrial tachyarrhythmias in this study was due to
careful programming of each pacemaker. To avoid problems, it
is essential to understand the pacemaker mode-switching
algorithm and to pay careful attention to the patient’s clinical
Figure 3. Preferred pacing period according to mode-switching algo-
rithms. FAST MS 5 fast mode-switching devices; SLOW MS 5 slow
mode-switching devices; other abbreviations as in Figure 2.
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history. Atrial sensitivity should be sufficiently high so that the
pacemaker consistently detects the atrial arrhythmia, espe-
cially during atrial fibrillation, as the atrial signal is often
smaller and more variable in size than during sinus rhythm
(21). Inappropriately long atrial blanking periods can result in
undersensing of atrial arrhythmias. These periods should thus
be programmed to be as short as possible. The atrial tachycar-
dia detection rate should always be set higher than the
patient’s maximal sinus rate but below the atrial tachyarrhyth-
mia rate to avoid inappropriate mode switching during sinus
tachycardia.
Preferred pacing mode. VR mode has previously been
advocated by some as the pacing mode of choice in patients
with a history of atrial tachyarrhythmias. In this study, one
third of patients terminated VR mode early because of marked
symptoms consistent with the pacemaker syndrome. No clini-
cal variables identified these patients. Only 14% of the patients
chose VR as their preferred pacing mode. In contrast DM
mode was preferred by 51% of the patients and was signifi-
cantly better than VR mode as assessed both subjectively and
objectively.
Previous studies in patients without a history of atrial
tachyarrhythmias (22–24) have also shown that dual-chamber
pacing is preferred to single-chamber ventricular rate-
responsive pacing, Menozzi et al. (22), in a randomized
crossover study of 14 patients with high degree AV block
Figure 4. A, Response of a fast mode-switching device (Diamond DR)
to atrial tachyarrhythmia. The second and third ECG complexes from
the left are sinus beats with ventricular tracking; this is followed by
atrial tachyarrhythmia and immediate mode switching (4th complex);
two beats of sinus rhythm (complexes 5 and 6) follow with immediate
resynchronization and tracking of p waves; longer run of atrial
tachyarrhythmia with immediate mode switching (complexes 7 and 8).
B, Response to atrial tachyarrhythmia of a slow mode-switching device
(Trilogy DR1). The second and third ECG complexes from the left
are sinus beats with ventricular tracking at a rate of 65 beats/min.
These are followed by a short run of atrial tachyarrhythmia that is
tracked at a rate of ;125 beats/min. The tachyarrhythmia terminates
before mode switching occurs.
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showed that patients were less symptomatic with DDD than
with VVIR pacing. In their study, 36% of patients crossed over
early from VR to DDD pacing because of intolerable symp-
toms. A study of similar design (23) comparing four pacing
modalities (DR, DDD, DDIR, dual-chamber inhibited rate-
responsive, VR) showed that patients were less symptomatic
and could exercise longer with DR than with VVIR mode.
Overall, in this study, DR was the preferred and VR the least
acceptable mode, and 24% of patients requested early termi-
nation of the VR mode. However, DR is not an acceptable
pacing mode in patients with a history of atrial tachyarrhyth-
mias. In our study, there were many cases of rapid tracking of
atrial tachyarrhythmias in DR mode, and 29% of patients with
significant atrial tachyarrhythmias terminated this mode early
because of adverse symptoms.
It is likely that the objective and subjective superiority of
DM over VR mode is predominantly due to maintenance of
AV synchrony during periods of sinus rhythm, but the higher
peak heart rates achieved during exercise may also be a
positive contributing factor. The higher heart rates achieved in
DR and DM modes occurred even though the sensor variables
were kept constant for each patient throughout the study. In
DM mode the physiologic sinus rate is tracked, whereas in VR
mode the increase in heart rate is completely dependent on the
sensor.
Study limitations. Our study had several limitations. 1) It
was not possible to perform a within-patient direct comparison
of different mode-switching algorithms (fast vs. slow) with the
available devices. 2) As with all subjective assessment, results
are dependent on patient mental state, and perception of
palpitation is especially susceptible. 3) Continuous ECG mon-
itoring throughout the study was unacceptable to all patients
and patient-activated recorders were therefore used in addi-
tion to intermittent Holter monitoring. This is susceptible to
the same constraints as in point 2 above.
Clinical implications. A history of atrial tachyarrhythmias
is no longer a contraindication to implantation of dual-
chamber pacemakers. Mode-switching pacemakers provide
adequate protection against rapid sustained tracking of atrial
tachyarrhythmias. Fast mode-switching devices are preferable
in patients with short-lived or frequent atrial tachyarrhythmias.
Because atrial tachyarrhythmias will develop in a significant
proportion of patients with a dual-chamber pacemaker, mode
switching may be a useful feature on all devices. Future studies
are required to determine predictors for development of
chronic atrial arrhythmias in patients with a history of parox-
ysmal atrial tachyarrhythmia before pacemaker implantation.
Conclusions. In patients with a history of paroxysmal atrial
tachyarrhythmias, dual-chamber rate-responsive pacing with
mode switching is preferred to single-chamber rate-responsive
ventricular pacing. Fast mode-switching devices may be more
appropriate in patients with frequent short-lived atrial tachy-
arrhythmias. With appropriate programming tailored to each
patient, inappropriate mode switching and tracking of atrial
tachyarrhythmias is very uncommon.
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